logo

For the Inventor, By the Inventor

Norristown, PA, United States of America

Irennegbe Kelly Osifo

This inventor holds 6 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 1997-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Irennegbe Kelly Osifo. Retrieved from https://idiyas.com/inventor/irennegbe-kelly-osifo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 4.7

ph-index = 6

Forward Citations = 196(Granted Patents)


Location History:

  • Eagleville, PA (US) (1997 - 2002)
  • Norristown, PA (US) (2004)

Company Filing History:

goldMedal6 out of 2,198 
 
Smithkline Beecham Corporation
 patents

Years Active: 1997-2004

Loading Chart...
6 patents (USPTO):Explore Patents
1. 6774127 - Pyrazole and pyrazoline substituted compounds (2004-08-10),
2. 6369068 - Amino substituted pyrimidine containing compounds (2002-04-09),
3. 6218537 - Process for making pyridyl and pyrimidine substituted imidazole compounds (2001-04-17),
4. 5869660 - Process of preparing imidazole compounds (1999-02-09),
5. 5739143 - Imidazole compounds and compositions (1998-04-14),
6. 5658903 - Imidazole compounds, compositions and use (1997-08-19),

Title: Irennegbe Kelly Osifo: Innovator in Therapeutic Compounds

Introduction

Irennegbe Kelly Osifo is a prominent inventor based in Norristown, PA (US). She has made significant contributions to the field of therapeutic compounds, holding a total of 6 patents. Her work focuses on developing novel compounds that have potential applications in medical therapies.

Latest Patents

Among her latest patents are innovative compounds such as pyrazole and pyrazoline substituted compounds. These compounds are designed for therapeutic use, showcasing their potential in treating various conditions. Additionally, she has developed amino substituted pyrimidine containing compounds, which include novel 1,4,5-substituted imidazole compounds aimed at serving as cytokine inhibitors.

Career Highlights

Irennegbe Kelly Osifo is currently employed at SmithKline Beecham Corporation, where she continues to advance her research and development efforts. Her work has been instrumental in creating new therapeutic options that could benefit patients in need of effective treatments.

Collaborations

Throughout her career, Irennegbe has collaborated with notable colleagues, including Jerry Leroy Adams and Timothy Francis Gallagher. These partnerships have contributed to her success and the advancement of her innovative projects.

Conclusion

Irennegbe Kelly Osifo stands out as a dedicated inventor whose work in therapeutic compounds is paving the way for new medical advancements. Her contributions are significant in the realm of innovation and invention, reflecting her commitment to improving healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…